Posting of Annual Report & Notice of AGM
Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Posting of Annual Report & Notice of AGM…
News
Posting of Annual Report & Notice of AGM
Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Posting of Annual Report & Notice of AGM…
Oncorus Reports First Quarter 2023 Financial Results and Provides Business Updates
IND submission for ONCR-021 still planned for mid-2023, subject to receipt of additional funding Ended…
Oncorus Reports First Quarter 2023 Financial Results and Provides Business Updates
IND submission for ONCR-021 still planned for mid-2023, subject to receipt of additional funding Ended…
Terns Pharmaceuticals to Highlight New Preclinical Data for TERN-601 Program in Obesity at the American Diabetes Association’s 83rd Annual Scientific Sessions
TERN-601 (oral GLP-1) program in obesity on track to initiate Phase 1 clinical trial in…
Terns Pharmaceuticals to Highlight New Preclinical Data for TERN-601 Program in Obesity at the American Diabetes Association’s 83rd Annual Scientific Sessions
TERN-601 (oral GLP-1) program in obesity on track to initiate Phase 1 clinical trial in…
Journey Medical Corporation Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
Achieved “Last Patient Out” milestone in Phase 3 clinical program evaluating DFD-29 in May 2023…
Journey Medical Corporation Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
Achieved “Last Patient Out” milestone in Phase 3 clinical program evaluating DFD-29 in May 2023…
Galapagos demonstrates commitment to immunology with new data in rheumatoid arthritis at EULAR 2023
9 poster presentations and 3 abstracts publications reinforce Galapagos’ commitment to immunology and the rheumatoid…
NexImmune Announces Poster Presentation at the 2023 FOCIS Annual Meeting
AIM nanoparticle approach can identify select EBV-specific T cell defects in patients with multiple sclerosis…
Ellington Financial Announces Common Stock Authorization
OLD GREENWICH, Conn.–(BUSINESS WIRE)–Ellington Financial Inc. (NYSE: EFC) (the “Company”) today announced that at its…
Esports Entertainment Group Provides Fiscal Third Quarter Business Update
Divests Non-Core Businesses in a Company Reset to Maximize Opportunities in the Esports and E-simulator…
Grupo Supervielle Reports 1Q23 Results
Delivered profitability with ROE at 2% in real terms; Tier 1 Capital Ratio at 14.7%…
Veeam Latin America Impact Partner Award Winners Announced
Veeam recognizes partners who have demonstrated outstanding performance and expertise in delivering Data Protection and…
Applied UV Reports Q1, 2023 Financial Results
Q1 2023 Revenue Increases 217% to $10.7 Million MOUNT VERNON, N.Y.–(BUSINESS WIRE)–Applied UV, Inc. (NasdaqCM:…
AmeriGas Partners, L.P. and AmeriGas Finance Corp. Price Senior Notes Offering
VALLEY FORGE, Pa.–(BUSINESS WIRE)–#AmeriGas–UGI Corporation (NYSE: UGI) announced today that its subsidiaries, AmeriGas Partners, L.P….
Aerovate Therapeutics Presents Nonclinical Pharmacokinetic Data in Support of AV-101, a Novel Dry Powder Inhaled Formulation of Imatinib, at the American Thoracic Society (ATS) 2023 International Conference
Direct delivery of imatinib to the lungs in nonclinical species demonstrated increased lung exposure compared…
Aerovate Therapeutics Presents Nonclinical Pharmacokinetic Data in Support of AV-101, a Novel Dry Powder Inhaled Formulation of Imatinib, at the American Thoracic Society (ATS) 2023 International Conference
Direct delivery of imatinib to the lungs in nonclinical species demonstrated increased lung exposure compared…
7 Hills Pharma Surpasses $25MM Milestone in Nondilutive Funding
HOUSTON, May 22, 2023 (GLOBE NEWSWIRE) — 7 Hills Pharma LLC (“7 Hills” or “7HP”)…
7 Hills Pharma Surpasses $25MM Milestone in Nondilutive Funding
HOUSTON, May 22, 2023 (GLOBE NEWSWIRE) — 7 Hills Pharma LLC (“7 Hills” or “7HP”)…